Andrew Kay

Chairman chez NUCANA PLC Fortune : - $ au 31/03/2024

Profil

Andrew Martin Kay is currently the Non-Executive Chairman at NuCana Plc and Ember Ltd.
He is also the Chairman at NeRRe Therapeutics Ltd., Blueberry Therapeutics Ltd., and Amulet Consulting Ltd.
Additionally, he serves as a Director at NeRRe Therapeutics Holdings Ltd.
and Chaperhome Ltd.
In the past, Mr. Kay held the position of President & Chief Executive Officer at Algeta ASA from 2009 to 2014.
He was also the Chairman at Wilson Therapeutics AB.
Prior to that, he served as the Executive Director-Commercial at Ultimate Finance Holdings Ltd.
and Renovo Ltd.
He was an Independent Director at KaNDy Therapeutics Ltd.
and held the role of Global Head-Marketing & Sales at Novartis UK Ltd.
from 1999 to 2003.
Mr. Kay completed his undergraduate degree at the School of Pharmacy.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
NUCANA PLC -.--%	31/12/2023	0 ( -.--% )	- $	31/03/2024

Postes actifs de Andrew Kay

Sociétés	Poste	Début
NUCANA PLC	Chairman	21/12/2020
Ember Ltd.	Chairman	-
Blueberry Therapeutics Ltd.	Chairman	-
Amulet Consulting Ltd.	Chairman	-
NeRRe Therapeutics Ltd.	Chairman	27/09/2017
NeRRe Therapeutics Holdings Ltd.	Director/Board Member	15/09/2017
Chaperhome Ltd.	Director/Board Member	18/02/2021

Anciens postes connus de Andrew Kay

Sociétés	Poste	Fin
ALGETA ASA	Chief Executive Officer	14/03/2014
INSPIRED CAPITAL PLC	Corporate Officer/Principal	31/12/2008
░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░ ░░░░	░░░░░ ░ ░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░	-

Formation de Andrew Kay

School of Pharmacy

Undergraduate Degree